Sam-A Pharm. Co. Ltd (009300) — Capital Reinvestment Ratio
Sam-A Pharm. Co. Ltd (009300) has a Capital Reinvestment Ratio of 4.23x as of December 2025, meaning it reinvests 4% of its operating cash flow (₩162.42 Million) in capital expenditures (₩687.24 Million). See 009300 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sam-A Pharm. Co. Ltd Capital Reinvestment Ratio (2010–2025)
This chart tracks Sam-A Pharm. Co. Ltd's Capital Reinvestment Ratio across 15 annual periods. Check Sam-A Pharm. Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sam-A Pharm. Co. Ltd (2010–2025)
Year-by-year Capital Reinvestment Ratio for Sam-A Pharm. Co. Ltd from 2010 to 2025. For live market cap and broader valuation context, see Sam-A Pharm. Co. Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | ₩10.72 Billion | ₩1.78 Billion | ▼ -35.7% |
| 2024 | 0.26x | ₩25.25 Billion | ₩6.51 Billion | ▲ +40.2% |
| 2023 | 0.18x | ₩20.76 Billion | ₩3.82 Billion | ▲ +1407.7% |
| 2022 | 0.01x | ₩19.60 Billion | ₩239.25 Million | ▼ -42.7% |
| 2021 | 0.02x | ₩12.94 Billion | ₩275.44 Million | ▼ -70.5% |
| 2020 | 0.07x | ₩9.41 Billion | ₩679.52 Million | ▲ +94.2% |
| 2019 | 0.04x | ₩13.22 Billion | ₩491.74 Million | ▼ -80.2% |
| 2018 | 0.19x | ₩12.76 Billion | ₩2.40 Billion | ▼ -73.9% |
| 2017 | 0.72x | ₩5.10 Billion | ₩3.68 Billion | ▲ +556.5% |
| 2016 | 0.11x | ₩10.53 Billion | ₩1.16 Billion | ▼ -60.8% |
| 2015 | 0.28x | ₩10.81 Billion | ₩3.03 Billion | ▲ +76.7% |
| 2014 | 0.16x | ₩11.38 Billion | ₩1.80 Billion | ▼ -57.8% |
| 2012 | 0.38x | ₩14.00 Billion | ₩5.26 Billion | ▲ +366.0% |
| 2011 | 0.08x | ₩10.47 Billion | ₩843.76 Million | ▼ -86.9% |
| 2010 | 0.62x | ₩5.10 Billion | ₩3.14 Billion | — |